Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Allison Dorval currently holds 90,780 shares of Verve Therapeutics, Inc. (VERV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allison Dorval has been a net seller of VERV stock. They have purchased $0 and sold $264.9K worth of shares.
Allison Dorval's most recent insider trade was on Jun 12, 2026, when they sold 11,610 shares at $7.20 per share.
Allison Dorval serves as Executive at Verve Therapeutics, Inc. (VERV). They have executed 28 insider transactions totaling $264.9K over their tenure at the company.
Allison Dorval holds the position of Executive at Verve Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Allison Dorval has shown a selling trading pattern, with $0 in total purchases and $264.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Allison Dorval was on Jun 12, 2026, when they sold $83.6K worth of PBYI shares. This transaction involved 11,610 shares at $7.20 per share.
Allison Dorval currently owns 90,780 shares of Verve Therapeutics, Inc. (VERV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Allison Dorval's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Allison Dorval has 28 Form 4 filings on record as an insider at Verve Therapeutics, Inc..
Set alerts for Allison Dorval and 40,000+ other insiders.